Pulsed Field Ablation (PFA) is a novel ablation technology that utilizes electric field strength to ablate tissue. PFA is unique in its cell selectivity, which is found in the biophysics of the bilipid membrane's sensitivity to electric fields. PFA permits an unseen level of flexibility in its delivery due to its non-abrasive ablation methods and ability to selectively ablate regardless of direct contact. With the ability to electrically isolate each electrode, it is possible to dynamically map and ablate according to patient-specific "mechanistic" targets. Testing was done to determine the efficacy of the PFA system, the influence that electrode configuration has on PFA lesion size, and the acute lesion formation timeline. PFA lesion depth can be doubled (1mm to 2mm) through modulating electrode configuration and polarity. Significant electrophysiological changes were only recorded immediately post ablation. Electrode configurations appeared to generate the same level of tissue damage at PFA sites while significantly increasing depth without increasing voltage, which could introduce more risks and complications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11883168 | PMC |
http://dx.doi.org/10.1109/EMBC53108.2024.10781848 | DOI Listing |
Cardiovasc Interv Ther
March 2025
Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine, Ohno-Higashi, Osakasayama, Osaka, 589-8511, Japan.
Identification of vulnerable plaques is important for reducing future cardiovascular events. This study aimed to investigate optimal modalities other than intravascular imaging in evaluating vulnerable plaques. We prospectively evaluated 105 non-culprit coronary lesions by CCTA imaging and near-infrared spectroscopy-intravascular ultrasound in 32 patients with acute coronary syndrome.
View Article and Find Full Text PDFRheumatol Int
March 2025
Department of Rheumatology and Connective Tissue Diseases, Medical University, St. Jaczewskiego 8, 20-090, Lublin, Poland.
Pancreatic panniculitis (PP) and arthritis may be extrapancreatic manifestations of pancreatic disease. The triad of pancreatic disease, panniculitis and polyarthritis, described in the literature as the PPP syndrome, is sometimes observed in patients with acute or chronic pancreatitis, pancreatic cancer or neuroendocrine tumors (NETs). We present a 60-year-old man with polyarthritis and clinically aggressive PP of the limbs.
View Article and Find Full Text PDFNanomaterials (Basel)
February 2025
School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Acute myocardial infarction, a leading cause of death globally, is often associated with cardiometabolic disorders such as atherosclerosis and metabolic syndrome. Metabolic treatment of these disorders can improve cardiac outcomes, as exemplified by the GLP-1 agonist semaglutide. Fibroblast growth factor 21 (FGF21), a novel metabolic regulator, plays pivotal roles in lipid mobilization and energy conversion, reducing lipotoxicity, inflammation, mitochondrial health, and subsequent tissue damage in organs such as the liver, pancreas, and heart.
View Article and Find Full Text PDFObjective: To analyze the effects of multiplane reconstruction (MPR) technology with multi-slice spiral CT (MSCT) in the etiological diagnosis of acute intestinal obstruction (AIO). Obtaining clear images is of great help in determining the type and etiology of AIO, and doctors can quickly develop treatment plans to improve prognosis and efficacy.
Methods: The clinical data of patients with suspected AIO admitted to our hospital from May 2020 to May 2022 were retrospectively selected as the observation objects.
Int J Gen Med
March 2025
Department of Cardiology, Tianjin Chest Hospital, Tianjin, People's Republic of China.
Background: Severe in-stent restenosis (ISR) following the implantation of drug-eluting stent (DES) can lead to recurrent angina pectoris or even acute myocardial infarction, thereby necessitating target lesion revascularization (TLR). Prior studies have confirmed the correlation between the monocyte to high-density lipoprotein cholesterol ratio (MHR) and ISR after DES implantation. The potential of MHR to predict TLR following DES implantation remains an area of ongoing research and may have significant clinical implications.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!